Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support

RecruitingOBSERVATIONAL
Enrollment

1,836

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

February 28, 2027

Conditions
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis
Interventions
DIAGNOSTIC_TEST

Routine Assays on fresh plasma

"Routine coagulation tests using STA-R Max analyzer :~Prothrombin Time (PT) activated Partial Thromboplastin Time (aPTT Thrombin Time (TT) Fibrinogen Anti-Xa activity"

DIAGNOSTIC_TEST

New Clinical Decision Support on fresh plasma

D-Dimer and fibrin formation assays on STA-R Max analyzer. Calculation of the exclusion score using an algorithm (manual or based on Machine Learning) compared to a Clinical Decision Support cut-off.

DIAGNOSTIC_TEST

New Clinical Decision Support on frozen plasma

D-Dimer and fibrin formation assays on STA-R Max analyzer. Calculation of the exclusion score using an algorithm (manual or based on Machine Learning) compared to a Clinical Decision Support cut-off.

Trial Locations (4)

72037

RECRUITING

Centre Hospitalier le Mans, Le Mans

79021

RECRUITING

Centre Hospitalier de Niort, Niort

Unknown

RECRUITING

CHU Dijon Bourgogne, Dijon

RECRUITING

University Hospital Grenoble, Grenoble

Sponsors
All Listed Sponsors
collaborator

Centre Hospitalier de Niort

OTHER

collaborator

Centre Hospitalier le Mans

OTHER

collaborator

Centre Hospitalier Universitaire Dijon

OTHER

collaborator

University Hospital, Grenoble

OTHER

lead

Diagnostica Stago R&D

INDUSTRY

NCT06480994 - Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support | Biotech Hunter | Biotech Hunter